In a study to observe their effect in DTC ads, comparison claims in both print and video ads led consumers to trust those drugs over rival medications, researchers found.
JAMA study links Parkinson’s drugs and compulsive behavior
October 21, 2014
6:17 pm
Researchers conclude that “more prominent warnings” are warranted for the class known as dopamine receptor agonists.
There are similarities between the 2014 formularies and their commercial counterparts. However, differences in the drug benefit designs show the predominance of four to five tiers, higher deductibles and higher copays or coinsurance levels compared to commercial benefits.
Rate of Sovaldi non-adherence points to need for patient support
A mélange of new treatments awaiting approval and a lack of patient support are driving down drug utilization for Gilead’s HCV blockbuster, according to a new study.